For Immediate Release: June 18, 2015

Mary Kuramoto
513-579-9911 x2523

Medpace Named a Top Cincinnati Workplace for 2015 by the Cincinnati Enquirer

CINCINNATI, OH – (June 18, 2015) – Medpace, is pleased to announce that it has been selected as one of Cincinnati’s Top Workplaces for 2015, as reported by the Cincinnati Enquirer. The Top Workplaces are determined based solely on employee feedback. The employee survey is conducted by WorkplaceDynamics, LLC, a leading research firm on organizational health and employee engagement. WorkplaceDynamics conducts regional Top Workplaces programs with 45 major publishing partners across the United States. Over the past year, more than 6,000 organizations and 1 in every 88 employees in the U.S. have turned to WorkplaceDynamics to better understand what’s on the minds of their employees. Through its workplace improvement offerings, WorkplaceDynamics provides solutions, training and tools to help clients improve their workplace.

In February 2015, all Cincinnati office based employees were asked to complete a survey about their employment at Medpace. As reported by the Enquirer, this survey included employees in our one location in the Cincinnati area and approximately 1,000 of our 1,200 United States based employees. As announced in the Cincinnati Enquirer on June 14th, Medpace has been named 5th of 15 large companies who have made the Top Workplaces list for 2015.

Medpace was also recognized as having the best management out of all 15 large workplaces. This resulted from having the highest rated responses to the questions about how employees feel about their manager. This attests to the high quality of leadership we have here at Medpace. This is a great accomplishment for Medpace and could not have been completed without the help of our employees. The Cincinnati Enquirer published the complete list of Top Workplaces on June 14th. For more information about the Top Workplaces lists and WorkplaceDynamics, please visit and


Medpace is a global full-service clinical research organization (CRO) providing Phase I-IV core development services for drug, biologic, and device programs. Medpace has strong experience supporting development programs across a number of therapeutic areas including oncology, cardiovascular, metabolic/diabetes, infectious disease, neuroscience, regenerative medicine, gastrointestinal diseases, pediatrics, and rare and orphan disease. With extensive medical expertise, and renowned regulatory affairs department, Medpace employs 1800 employees and has clinical trial experience in over 47 countries and 6 regions – North America, Europe, Asia Pacific, Latin America, Africa, and the Middle East. From feasibility, research site compatibility, safety, and logistics, Medpace brings efficiencies and operational excellence to both drug and device development programs. In addition, Medpace offers integrated imaging, central and bioanalytical lab capabilities, and clinical pharmacology through wholly-owned business units to provide cohesive, streamlined, and standardized trial management.

For more information, please visit